Clinical trial data shows Oxford University’s COVID-19 vaccine produces strong immune response

Read full release

First participant dosed in Phase 1 clinical study with VTP-300 immunotherapeutic to treat chronically infected Hepatitis B patients

Read full release

Vaccitech and Oxford University announce landmark partnership with AstraZeneca for the development and large-scale distribution of the COVID-19 vaccine candidate

Read full release

Vaccitech and Oxford University Announce Promising Phase 2a Data on Prostate Cancer Immunotherapy

Read full release